214 related articles for article (PubMed ID: 31717736)
21. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
[TBL] [Abstract][Full Text] [Related]
22. Sarcopenia, cachexia and congestive heart failure in the elderly.
Zamboni M; Rossi AP; Corzato F; Bambace C; Mazzali G; Fantin F
Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):58-67. PubMed ID: 23369138
[TBL] [Abstract][Full Text] [Related]
23. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
[TBL] [Abstract][Full Text] [Related]
24. Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact.
Prado CM; Cushen SJ; Orsso CE; Ryan AM
Proc Nutr Soc; 2016 May; 75(2):188-98. PubMed ID: 26743210
[TBL] [Abstract][Full Text] [Related]
25. Pentraxin 3 is an adipose tissue-related serum marker for pancreatic cancer cachexia predicting subsequent muscle mass and visceral fat loss.
Sato K; Hikita H; Shigekawa M; Kato S; Sasaki Y; Shinkai K; Fukuoka M; Kudo S; Sato Y; Fukumoto K; Shirai K; Myojin Y; Sakane S; Murai K; Yoshioka T; Nishio A; Kodama T; Sakamori R; Tatsumi T; Takehara T
Cancer Sci; 2022 Dec; 113(12):4311-4326. PubMed ID: 36074525
[TBL] [Abstract][Full Text] [Related]
26. Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer.
Babic A; Rosenthal MH; Bamlet WR; Takahashi N; Sugimoto M; Danai LV; Morales-Oyarvide V; Khalaf N; Dunne RF; Brais LK; Welch MW; Zellers CL; Dennis C; Rifai N; Prado CM; Caan B; Sundaresan TK; Meyerhardt JA; Kulke MH; Clish CB; Ng K; Vander Heiden MG; Petersen GM; Wolpin BM
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2062-2069. PubMed ID: 31533940
[TBL] [Abstract][Full Text] [Related]
27. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.
Tamandl D; Paireder M; Asari R; Baltzer PA; Schoppmann SF; Ba-Ssalamah A
Eur Radiol; 2016 May; 26(5):1359-67. PubMed ID: 26334504
[TBL] [Abstract][Full Text] [Related]
28. Long-term Clinical Outcomes of Nonoperative Management With Chemoradiotherapy for Locally Advanced Rectal Cancer in the Veterans Health Administration.
Spiegel DY; Boyer MJ; Hong JC; Williams CD; Kelley MJ; Moore H; Salama JK; Palta M
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):565-573. PubMed ID: 30359718
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
[TBL] [Abstract][Full Text] [Related]
30. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
[TBL] [Abstract][Full Text] [Related]
31. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract][Full Text] [Related]
32. Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer.
Choi MH; Yoon SB; Lee K; Song M; Lee IS; Lee MA; Hong TH; Choi MG
J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):326-334. PubMed ID: 29399990
[TBL] [Abstract][Full Text] [Related]
33. Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect.
Beluzi M; Peres SB; Henriques FS; Sertié RA; Franco FO; Santos KB; Knobl P; Andreotti S; Shida CS; Neves RX; Farmer SR; Seelaender M; Lima FB; Batista ML
PLoS One; 2015; 10(3):e0122660. PubMed ID: 25807446
[TBL] [Abstract][Full Text] [Related]
34. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
[TBL] [Abstract][Full Text] [Related]
36. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
[TBL] [Abstract][Full Text] [Related]
37. Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Adv Gerontol; 2006; 18():39-54. PubMed ID: 16676797
[TBL] [Abstract][Full Text] [Related]
38. Skeletal Muscle Loss Is an Imaging Biomarker of Outcome after Definitive Chemoradiotherapy for Locally Advanced Cervical Cancer.
Lee J; Chang CL; Lin JB; Wu MH; Sun FJ; Jan YT; Hsu SM; Chen YJ
Clin Cancer Res; 2018 Oct; 24(20):5028-5036. PubMed ID: 29959140
[No Abstract] [Full Text] [Related]
39. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer.
Kishi T; Nakamura A; Itasaka S; Shibuya K; Matsumoto S; Kanai M; Kodama Y; Takaori K; Mizowaki T; Hiraoka M
Pancreatology; 2015; 15(6):694-700. PubMed ID: 26601881
[TBL] [Abstract][Full Text] [Related]
40. Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer.
Silvério R; Lira FS; Oyama LM; Oller do Nascimento CM; Otoch JP; Alcântara PSM; Batista ML; Seelaender M
Lipids Health Dis; 2017 Aug; 16(1):159. PubMed ID: 28830524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]